[{"notes_id":"1_509","category":"5","subcategory":"1","title":"Hepatitis C","body":"Hepatitis C is likely to become a significant public health problem in the UK in the next decade. It is thought around 200,000 people are chronically infected with the virus. At risk groups include <span class=\"concept\" data-cid=\"6838\">intravenous drug users<\/span> and patients who received a blood transfusion prior to 1991 (e.g. haemophiliacs).<br \/><br \/>Pathophysiology<br \/><ul><li>hepatitis C is a <span class=\"concept\" data-cid=\"6841\">RNA flavivirus<\/span><\/li><li>incubation period: 6-9 weeks<\/li><\/ul><br \/><span class=\"concept\" data-cid=\"6842\">Transmission<\/span><br \/><ul><li>the risk of transmission during a needle stick injury is <span class=\"concept\" data-cid=\"9455\">about 2%<\/span><\/li><li>the vertical transmission rate from mother to child is <span class=\"concept\" data-cid=\"3423\">about 6%<\/span>. The risk is higher if there is coexistent HIV<\/li><li>breastfeeding is not contraindicated in mothers with hepatitis C<\/li><li>the risk of transmitting the virus during sexual intercourse is probably less than 5%<\/li><li>there is <span class=\"concept\" data-cid=\"6839\">no vaccine for hepatitis C<\/span><\/li><\/ul><br \/>After exposure to the hepatitis C virus only around 30% of patients will develop features such as:<br \/><ul><li>a transient rise in serum aminotransferases \/ jaundice<\/li><li>fatigue<\/li><li>arthralgia<\/li><\/ul><br \/>Investigations<br \/><ul><li>HCV RNA is the investigation of choice to diagnose acute infection<\/li><li>whilst patients will eventually develop anti-HCV antibodies it should be remembered that <span class=\"concept\" data-cid=\"12495\">patients who spontaneously clear the virus will continue to have anti-HCV antibodies<\/span><\/li><\/ul><br \/>Outcome<br \/><ul><li>around 15-45% of patients will clear the virus after an acute infection (depending on their age and underlying health) and hence the majority (<span class=\"concept\" data-cid=\"726\">55-85%<\/span>) will develop <span class=\"concept\" data-cid=\"6831\">chronic hepatitis C<\/span><\/li><\/ul><br \/><br \/><h5 class='notes-heading'>Chronic hepatitis C<\/h5><br \/>Chronic hepatitis C may be defined as the persistence of HCV RNA in the blood for 6 months.<br \/><br \/>Potential complications of chronic hepatitis C<br \/><ul><li>rheumatological problems: arthralgia, arthritis<\/li><li>eye problems: Sjogren's syndrome<\/li><li><span class=\"concept\" data-cid=\"6832\">cirrhosis<\/span> (5-20% of those with chronic disease)<\/li><li><span class=\"concept\" data-cid=\"6833\">hepatocellular cancer<\/span><\/li><li><span class=\"concept\" data-cid=\"6834\">cryoglobulinaemia<\/span>: typically type II (mixed monoclonal and polyclonal)<\/li><li>porphyria cutanea tarda (PCT): it is increasingly recognised that PCT may develop in patients with hepatitis C, especially if there are other factors such as alcohol abuse<\/li><li>membranoproliferative glomerulonephritis<\/li><\/ul><br \/><br \/>Management of chronic infection<br \/><ul><li>treatment depends on the viral genotype - this should be tested prior to treatment<\/li><li>the management of hepatitis C has advanced rapidly in recent years resulting in clearance rates of around 95%. Interferon based treatments are no longer recommended<\/li><li>the aim of treatment is sustained virological response (SVR), defined as undetectable serum HCV RNA six months after the end of therapy<\/li><li>currently a combination of protease inhibitors (e.g. daclatasvir + sofosbuvir or sofosbuvir + simeprevir) with or without ribavirin are used<\/li><\/ul><br \/><br \/>Complications of treatment<br \/><ul><li>ribavirin - side-effects: haemolytic anaemia, cough. Women should not become pregnant within 6 months of stopping ribavirin as it is teratogenic<\/li><li>interferon alpha - side-effects: flu-like symptoms, depression, fatigue, leukopenia, thrombocytopenia<\/li><\/ul>","notes_hash":"25d71cfacaddeea968e9d2da2ea47356","knowledge_graph_node_id_link":1200,"links":"<table style='width:100%'><tr><td>European Association for the Study of the Liver<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1528\" data-linkid=\"1528\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1528\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1528\" data-linkid=\"1528\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1528\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">2<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/easl.eu\/wp-content\/uploads\/2018\/10\/HepC-English-report.pdf\">2018 EASL Recommendations on Treatment of Hepatitis C<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/0XXp5jpq85s\" data-description=\"Hepatitis\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"112\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/0XXp5jpq85s\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/0XXp5jpq85s\" data-description=\"Hepatitis\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"112\">Hepatitis<\/a><\/td><\/tr><tr><td><span ><small>Podmedics - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_201\" data-mediaid=\"201\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_201\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1<\/span><button type=\"button\" style=\"\" id=\"media_dislike_201\" data-mediaid=\"201\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_201\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/B9j3VuiU-s8\" data-description=\"Viral hepatitis\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"3\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/B9j3VuiU-s8\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/B9j3VuiU-s8\" data-description=\"Viral hepatitis\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"3\">Viral hepatitis<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_76\" data-mediaid=\"76\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_76\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4<\/span><button type=\"button\" style=\"\" id=\"media_dislike_76\" data-mediaid=\"76\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_76\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/5ClB3C622Q4\" data-description=\"Anti-hepatitis medications\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1355\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/5ClB3C622Q4\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/5ClB3C622Q4\" data-description=\"Anti-hepatitis medications\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1355\">Anti-hepatitis medications<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2383\" data-mediaid=\"2383\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2383\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2383\" data-mediaid=\"2383\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2383\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"6831":{"concept_text":"Hepatitis C complication - chronic hepatitis","concept_percentile":"20"},"6832":{"concept_text":"Hepatitis C complication - liver cirrhosis","concept_percentile":"4"},"6833":{"concept_text":"Hepatitis C complication - hepatocellular cancer","concept_percentile":"13"},"6834":{"concept_text":"Hepatitis C complication - cryoglobulinaemia","concept_percentile":"8"},"6838":{"concept_text":"Causes the most morbidity in IVDUs - hepatitis C","concept_percentile":"37"},"6839":{"concept_text":"Cannot be vaccinated against - hepatitis C","concept_percentile":"42"},"6842":{"concept_text":"Hepatitis C is spread by the parenteral, sexual and vertical transmission route","concept_percentile":"18"}},"category_name":"Infectious disease \/ Haematology \/ Immunology","subcategory_name":"Infectious disease","comment_count":9},"",[]]